CoChat

Cleavage at the amino and carboxyl termini of Alzheimer's amyloid-beta by cathepsin D

Open access
Ladror, U.S., Snyder, S.W., Wang, G.T., Holzman, T.F., Krafft, G.A. · 1994 · Journal of Biological Chemistry
Cited by 129

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

Amyloid P (A@) is a 3943-residue protein that originates from proteolysis of the P-protein precursor (PPP) and accumulates in senile plaques in brains of Alzheimer's disease (AD) patients.Mutant PPP, which incorporates an AD-causing double mutation at positions 687- 688, has been shown to enhance AP production in transfected cells.In this work we investigate the susceptibility of the mutant PPP sequence to proteolytic cleavage by proteinases from human brain.Internally quenched fluorogenic substrates were used that encompass the NH,-terminal sequence of AP from wild-type PPP, the double mutant, and the two single substitutions.Proteinase activity in brain extract cleaved the mutant substrate 100-fold faster than the wild-type substrate and the partial mutants 25-fold faster.The major cleavage site in all substrates was at the amyloidogenic Asp' site.The brain activity appeared to be cathepsin D (CD), as indicated by similarities to purified CD in 1) the rate and site of substrates cleavage, 2) the pH optima, and 3) the sensitivity to pepstatin A. The increased activity against the mutant substrate was not shared by cathepsins B and C, pepsin, HIV proteinase, and Candida albicans Asp-proteinase.Furthermore, CD cleaved a substrate that incorporates the COOH terminus of AP at positions equivalent to Thr4' andAla42, at ratios of 68% and 32%, respectively.CD degraded AP 1-40 into six fragments but AP 1-42 was completely resistant to digestion, probably because of its aggregation characteristics.These results indicate that CD is capable of producing the cleavages resulting in AP production and that it may prove to be a 'suitable therapeutic target.The formation of extracellular amyloid deposits in brains of Alzheimer's disease (AD)' patients is one of the hallmarks of the disease.The major component of the amyloid is the 39-43residue peptide, known as amyloid-p (AP) (see Ref. 1 for review), which is derived by proteolytic processing of a 110-135-kDa integral membrane protein termed amyloid-p precursor protein (PPP) (1).Considerable evidence implicates AP in the etiology of AD, the strongest of which was obtained from a National Institute on Aging Grant AG10481.The costs of publication of

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0021-9258(17)32325-6

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Cited by

See all 129

Metadata

Authors
Ladror, U. S., Snyder, S. W., Wang, G. T., Holzman, T. F., & Krafft, G. A.
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
1994-07
Volume
269
Issue
28
Pages
18422-18428
ISSN
0021-9258 (ISSN-L)
OpenAlex
W1483408272
Cited by
129
References
10
FWCI
7.26
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cleavage at the amino and carboxyl termini of Alzheimer's amyloid-beta by cathepsin D. https://app.cochat.ai/papers/10.1016/s0021-9258(17)32325-6
The paper
Ladror, U. S., Snyder, S. W., Wang, G. T., Holzman, T. F., & Krafft, G. A. (1994). Cleavage at the amino and carboxyl termini of Alzheimer's amyloid-beta by cathepsin D. Journal of Biological Chemistry. https://doi.org/10.1016/s0021-9258(17)32325-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.